Colorectal liver metastases: surgery, ablation and treatment order

Confirm that the liver lesions are colorectal metastases

A liver deposit from colorectal cancer is treated as colorectal cancer, not as a primary liver cancer such as hepatocellular carcinoma. This affects the medicines and the purpose of local treatment. The team uses the cancer history and imaging, with tissue sampling when it would resolve a meaningful uncertainty.

Bring the original bowel pathology, current scans and older scans showing how the lesions developed. Small deposits may be difficult to interpret or may become less visible after chemotherapy. The pretreatment images can therefore remain important even when the latest report sounds reassuring.

Sources and references: [1]

Resectability is a surgical assessment

The number of lesions is only part of the assessment. Surgeons consider their distribution, proximity to major vessels and bile ducts, and how much healthy liver would remain after treatment. They also review liver function, prior chemotherapy and disease outside the liver.

Ask the reviewer to state why the disease is removable or currently not removable. A useful explanation identifies the limiting issue, such as the required liver remnant or uncontrolled disease elsewhere. This makes it possible to understand whether systemic treatment, a staged strategy or another local method could change the situation.

Sources and references: [1]

What liver surgery is trying to achieve

Surgery aims to remove suitable deposits with an adequate margin while preserving sufficient liver. The operation may be limited or extensive, depending on location. When both the bowel tumor and liver disease need surgery, the team compares combined and staged approaches.

Ask about the expected admission, recovery and interruption of systemic treatment. The complications and recovery burden should be weighed against the intended cancer-control benefit. If different teams recommend different operations, request a review of the same complete image set and a clear account of their assumptions.

Sources and references: [1]

Where ablation may fit

Thermal ablation destroys a tumor in place. It can be useful for selected liver deposits, alone or alongside surgery. Lesion size, accessibility and nearby structures affect whether the team can achieve a satisfactory treatment zone without unacceptable damage.

Ask how ablation compares with resection for your particular deposits, including the chance of needing another local procedure. If one lesion is near a major vessel or a bile duct, its treatment may differ from another lesion in the same liver. A single technique does not have to be used for every site.

Sources and references: [1]

Why chemotherapy may come before or after local treatment

Systemic therapy can treat microscopic disease and sometimes reduce deposits enough to make local treatment feasible. A plan may use chemotherapy before surgery, afterward or on both sides of the procedure. Tumor biology and the initial resectability assessment shape the sequence.

The team should specify when scans will be reviewed and when a surgeon will reassess them. If surgery is a realistic goal, that reassessment needs to be part of the plan from the start. Molecular findings such as RAS, BRAF and MSI/MMR can also influence the systemic regimen.

Sources and references: [1]

Review disease outside the liver and the bowel primary

A technically removable liver lesion may still be part of widespread disease. Conversely, limited extrahepatic disease may need a more nuanced discussion. The team must explain how every important site will be managed, rather than treating the liver image in isolation.

Symptoms from the bowel primary can change priorities. Obstruction or heavy bleeding may need attention before an elective liver procedure. Ask whether the proposed order is driven by immediate symptoms, disease control or the technical requirements of surgery.

Sources and references: [1]

Leave the consultation with a reassessment plan

Useful questions include: can all visible disease be treated; what will remain afterward; what is the role of systemic therapy; and what would change the recommendation? Ask whether the intended result is complete local clearance or control of a specific problem.

Also establish the follow-up arrangements. Further liver or extrahepatic recurrence can occur after local treatment, so ongoing surveillance is essential. Keep the procedure report and treatment map, including the sites ablated, for future imaging review.

Sources and references: [1]

Organize a joint review in Shanghai

Fudan University Shanghai Cancer Center's colorectal service includes treatment of colorectal disease involving the liver. The hospital profile can support a request for coordinated surgical and oncology assessment.

EastMedGo can help prepare the scan timeline and ask which specialties should review the case together. Send the latest recommendation and the reason given for inoperability, if applicable, through contact. We can help clarify records transfer, consultation scheduling and expected charges before you decide on travel.

Sources and references: [2]

Common questions